Imagion Biosystems Limited (ASX:IBX)
Australia
· Delayed Price · Currency is AUD 0.0130
-0.0010 (-7.14%)
Apr 24, 2025, 3:45 PM AEST
Imagion Biosystems Revenue
In the year 2024, Imagion Biosystems had annual revenue of 2.67M AUD, down -46.38%. Imagion Biosystems had revenue of 1.03M in the half year ending December 31, 2024, a decrease of -63.28%.
Revenue
2.67M
Revenue Growth
-46.38%
P/S Ratio
0.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.67M | -2.31M | -46.38% |
| Dec 31, 2023 | 4.97M | 1.90M | 61.87% |
| Dec 31, 2022 | 3.07M | 215.36K | 7.54% |
| Dec 31, 2021 | 2.86M | 158.60K | 5.88% |
| Dec 31, 2020 | 2.70M | 206.96K | 8.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |